NMS Group S.p.A. is the largest company in Italy committed in innovation and oncology R&D.

With 420 total employees, NMS Group employs over 200 qualified researchers involved in research and development, from 'target validation'​ to phase II clinical trials.

NMS Group S.p.A. is the only company in Italy able to manage the entire integrated chain of the research and development path: from pre-clinical phase of research, to First-Time-In-Man of clinical phase, up to production and packaging of the finished drug.

The Group also provides services of Research and Production addressed to local and international markets through three different companies: Accelera, one of the few companies engaged in preclinical research in Italy; Clioss engaged in clinical development starting from First-Time-In-Man and Nerpharma, dealing with activities from formulation to production of the active principle.

Life Sciences

Pharmaceutical

Research

Therapeutics

NMS Group

Hugues Dolgos

Arianna Startari

Rosita Lupi

Enrico Girani

Tiziano Andreoli

The Science and Research Team at NMS Group focuses on driving innovation and advancement in oncology R&D. This team is responsible for all stages of the research and development process—from target validation and preclinical studies to phase II clinical trials. Their work is crucial in developing new treatments and therapies for cancer, leveraging expertise across multiple scientific disciplines to ensure the highest standards in drug discovery and development.

Science and Research Team

Business and Financial Operations

��

Science and Research Team

About

Team members

Other teams at NMS Group

Business and Financial Operations

��������

Science and Research Team

About

Team members

Other teams at NMS Group

Business and Financial Operations

��